Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04617548 · ClinicalTrials.gov registry record · Phase 1
tDCS and CO-OP in Chronic Stroke
A Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT04617548 is a Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 8 participants.
The verdict
NCT04617548, a Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This project seeks to evaluate the acceptability feasibility, practicality feasibility, and preliminary effect of combining transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) in individuals with chronic stroke.
Interventions
- COMBINATION_PRODUCT tDCS and CO-OP Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04617548
The ClinicalTrials.gov registry entry for NCT04617548 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS and CO-OP Group is the first listed.
NCT04617548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04617548 about?
NCT04617548 is a clinical study titled "tDCS and CO-OP in Chronic Stroke". This project seeks to evaluate the acceptability feasibility, practicality feasibility, and preliminary effect of combining transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) in individuals with chronic stroke.
What is the current status of trial NCT04617548?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2020-01-01. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04617548?
The interventions under investigation include: tDCS and CO-OP Group (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04617548?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.